메뉴 건너뛰기




Volumn 92, Issue 1, 2007, Pages 85-89

Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation

Author keywords

ABO compatibility; Allogeneic haematopoietic stem cell transplantation; Nonmyeloablative conditioning regimen; Pure red cell aplasia

Indexed keywords

AMSACRINE; ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; ISOHAEMAGGLUTININ ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

EID: 33845659139     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00865.x     Document Type: Article
Times cited : (12)

References (24)
  • 1
    • 4444262896 scopus 로고    scopus 로고
    • ABO-incompatible bone marrow transplantation: A GITMO survey of current practice in Italy and comparison with the literature
    • on behalf of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
    • Raimondi R, Soli M, Lamparelli T, Bacigalupo A, Arcese W, Belloni M, Rodeghiero F, on behalf of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO): ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 2004; 34:321-329
    • (2004) Bone Marrow Transplant , vol.34 , pp. 321-329
    • Raimondi, R.1    Soli, M.2    Lamparelli, T.3    Bacigalupo, A.4    Arcese, W.5    Belloni, M.6    Rodeghiero, F.7
  • 2
    • 0027052260 scopus 로고
    • Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow
    • Schanz U, Gmur J: Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow. Bone Marrow Transplant 1992; 10:507-513
    • (1992) Bone Marrow Transplant , vol.10 , pp. 507-513
    • Schanz, U.1    Gmur, J.2
  • 3
    • 0019945328 scopus 로고
    • Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion
    • Braine HG, Sensenbrenner LL, Wright SK, Tutschka PJ, Saral R, Santos GW: Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 1982; 60:420-425
    • (1982) Blood , vol.60 , pp. 420-425
    • Braine, H.G.1    Sensenbrenner, L.L.2    Wright, S.K.3    Tutschka, P.J.4    Saral, R.5    Santos, G.W.6
  • 4
    • 27744510891 scopus 로고    scopus 로고
    • Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch
    • Scholl S, Klink A, Mugge LO, Schilling K, Hoffken K, Sayer HG: Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch. Transfusion 2005; 45:1676-1683
    • (2005) Transfusion , vol.45 , pp. 1676-1683
    • Scholl, S.1    Klink, A.2    Mugge, L.O.3    Schilling, K.4    Hoffken, K.5    Sayer, H.G.6
  • 7
    • 0344034835 scopus 로고    scopus 로고
    • Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: Removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption
    • Rabitsch W, Knobl P, Prinz E, Keil F, Greinix H, Kalhs P, Worel N, Jansen M, Horl WH, Derfler K: Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption. Bone Marrow Transplant 2003; 32:1015-1019
    • (2003) Bone Marrow Transplant , vol.32 , pp. 1015-1019
    • Rabitsch, W.1    Knobl, P.2    Prinz, E.3    Keil, F.4    Greinix, H.5    Kalhs, P.6    Worel, N.7    Jansen, M.8    Horl, W.H.9    Derfler, K.10
  • 8
    • 0031451084 scopus 로고    scopus 로고
    • Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin
    • Santamaria A, Sureda A, Martino R, Domingo-Albos A, Muniz-Diaz E, Brunet S: Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin. Bone Marrow Transplant 1997; 20:1105-1107
    • (1997) Bone Marrow Transplant , vol.20 , pp. 1105-1107
    • Santamaria, A.1    Sureda, A.2    Martino, R.3    Domingo-Albos, A.4    Muniz-Diaz, E.5    Brunet, S.6
  • 9
    • 0035885919 scopus 로고    scopus 로고
    • Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
    • Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, Barrett AJ, Childs RW: Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001; 98:1687-1694
    • (2001) Blood , vol.98 , pp. 1687-1694
    • Bolan, C.D.1    Leitman, S.F.2    Griffith, L.M.3    Wesley, R.A.4    Procter, J.L.5    Stroncek, D.F.6    Barrett, A.J.7    Childs, R.W.8
  • 10
    • 9444242668 scopus 로고    scopus 로고
    • Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion
    • Verholen F, Stalder M, Helg C, Chalandon Y: Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Eur J Haematol 2004; 73:441-446
    • (2004) Eur J Haematol , vol.73 , pp. 441-446
    • Verholen, F.1    Stalder, M.2    Helg, C.3    Chalandon, Y.4
  • 11
  • 12
    • 0036750861 scopus 로고    scopus 로고
    • Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia
    • Maschan AA, Skorobogatova EV, Balashov DN, Pashanov ED, Trakhtman PE, Schipitzina IP, Skvortsova YV, Rumiantzev AG: Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002; 30:405-407
    • (2002) Bone Marrow Transplant , vol.30 , pp. 405-407
    • Maschan, A.A.1    Skorobogatova, E.V.2    Balashov, D.N.3    Pashanov, E.D.4    Trakhtman, P.E.5    Schipitzina, I.P.6    Skvortsova, Y.V.7    Rumiantzev, A.G.8
  • 18
    • 0033951894 scopus 로고    scopus 로고
    • Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
    • Lee JH, Lee KH, Kim S, Lee JH, Lee KH, Kim S, Lee JS, Kim SH, Kwon SW, Kim WK: Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25:179-184
    • (2000) Bone Marrow Transplant , vol.25 , pp. 179-184
    • Lee, J.H.1    Lee, K.H.2    Kim, S.3    Lee, J.H.4    Lee, K.H.5    Kim, S.6    Lee, J.S.7    Kim, S.H.8    Kwon, S.W.9    Kim, W.K.10
  • 20
    • 0033753941 scopus 로고    scopus 로고
    • Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning
    • Veelken H, Wasch R, Behringer D, Bertz H, Finke J: Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning. Bone Marrow Transplant 2000; 26:911-915
    • (2000) Bone Marrow Transplant , vol.26 , pp. 911-915
    • Veelken, H.1    Wasch, R.2    Behringer, D.3    Bertz, H.4    Finke, J.5
  • 21
    • 0023832322 scopus 로고
    • Immunohematologic consequences of major ABO-mismatched bone marrow transplantation
    • Sniecinski IJ, Oien L, Petz LD, Blume KG: Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45:530-534
    • (1988) Transplantation , vol.45 , pp. 530-534
    • Sniecinski, I.J.1    Oien, L.2    Petz, L.D.3    Blume, K.G.4
  • 22
    • 0034254282 scopus 로고    scopus 로고
    • Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect
    • Mielcarek M, Leisenring W, Torok-Storb B, Storb R: Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000; 96:1150-1156
    • (2000) Blood , vol.96 , pp. 1150-1156
    • Mielcarek, M.1    Leisenring, W.2    Torok-Storb, B.3    Storb, R.4
  • 23
    • 20044369903 scopus 로고    scopus 로고
    • Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation
    • Griffith LM, McCoy JP Jr, Bolan CD, Stroncek DF, Pickett AC, Linton GF, Lundqvist A, Srinivasan R, Leitman SF, Childs RW: Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005; 128:668-675
    • (2005) Br J Haematol , vol.128 , pp. 668-675
    • Griffith, L.M.1    McCoy Jr., J.P.2    Bolan, C.D.3    Stroncek, D.F.4    Pickett, A.C.5    Linton, G.F.6    Lundqvist, A.7    Srinivasan, R.8    Leitman, S.F.9    Childs, R.W.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.